The Herbert Wertheim School of Public Health and Human Longevity Science is innovating 21st century public health research and education.
A multidisciplinary team led by researchers at UC San Diego has received $1.2 million from the National Science Foundation (NSF) to create a novel system to study and inform the treatment of chronic low back pain.
UC San Diego scientists will lead several components of Bridge2AI, a new NIH-funded program to promote the use of AI in health and research.
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.
Brookie Best, PharmD, has been named the next dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, succeeding James McKerrow, PhD, MD, who stepped down June 30, 2022.
New UC San Diego Rady School of Management study is first to track smoking behavior at the individual level during the pandemic.
UC San Diego Herbert Wertheim School of Public Health and Human Longevity Study reports that epigenetic age acceleration is associated with lower odds of living to be 90 years old and could be used as a biomarker for healthy longevity and to estimate functional and cognitive aging.
New York Times, August 28
Washington Post, August 25
Washington Post, August 11
Elle, August 7
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
